Caldeira Daniel, Brito Dulce, Aguiar Carlos, Silva Cardoso José, Fonseca Cândida, Franco Fátima, Macedo Filipe, Moura Brenda, Pinto Fausto J, Vaz-Carneiro António
Serviço de Cardiologia, Hospital Universitário de Santa Maria - CHULN, Portugal; Centro Cardiovascular da Universidade de Lisboa (CCUL@RISE), CAML, Faculdade de Medicina, Universidade de Lisboa, Portugal; Laboratory of Clinical Pharmacology and Therapeutics and Centro de Estudos de Medicina Baseada na Evidência (CEMBE), Faculdade de Medicina da Universidade de Lisboa, Portugal.
Serviço de Cardiologia, Hospital Universitário de Santa Maria - CHULN, Portugal; Centro Cardiovascular da Universidade de Lisboa (CCUL@RISE), CAML, Faculdade de Medicina, Universidade de Lisboa, Portugal.
Rev Port Cardiol. 2023 Nov;42(11):885-891. doi: 10.1016/j.repc.2023.01.027. Epub 2023 May 29.
Heart failure (HF) has significant morbidity and mortality, and its prevalence will continue to increase in the future. This unfavorable evolution requires reflection as well as recommendations and decisions based on expert critical and strategic appraisal.
In the Acceleration on Heart Failure Empowerment and Awareness - the Portuguese Challenge (ATHENA-PT) study, a range of strategic factors that represent the strengths, weaknesses, threats, and opportunities (SWOT) of HF in Portugal were established. These factors were assessed quantitatively by experts, to create a final SWOT matrix for the management and prevention of HF in Portugal and to outline recommendations.
For HF management, the panel emphasized the following strategic recommendations: (i) reimbursement of natriuretic peptides testing in primary healthcare; (ii) reimbursement of Doppler assessment in echocardiographic studies and promotion of detailed information in reports; (iii) intervention to improve the prognosis of patients with HF with preserved ejection fraction; (iv) ensuring effective healthcare transition between hospital and ambulatory units, using checklists/protocols; and (v) reinforcement and commitment to the training of primary health physicians and to the cardiac rehabilitation of patients. For the prevention of HF, the following recommendations/proposals were proposed: (i) campaigns to raise awareness of cardiovascular disease risk factors; (ii) promotion of physical exercise and healthy eating; and (iii) avoidance of therapeutic inertia in the management of risk factors.
The acknowledgment of various strategic factors and their prioritization by experts made it possible to create and reinforce a range of new strategic recommendations for the management and prevention of HF.
心力衰竭(HF)具有显著的发病率和死亡率,且其患病率在未来还将持续上升。这种不利的发展态势需要进行反思,并基于专家的批判性和战略性评估提出建议及做出决策。
在“心力衰竭赋权与认知加速——葡萄牙挑战”(ATHENA-PT)研究中,确定了一系列代表葡萄牙心力衰竭的优势、劣势、威胁和机遇(SWOT)的战略因素。专家们对这些因素进行了定量评估,以创建葡萄牙心力衰竭管理与预防的最终SWOT矩阵,并概述相关建议。
对于心力衰竭管理,专家组强调了以下战略建议:(i)在初级医疗保健中报销利钠肽检测费用;(ii)报销超声心动图研究中的多普勒评估费用,并促进报告中的详细信息;(iii)对射血分数保留的心力衰竭患者进行干预以改善预后;(iv)使用检查表/协议确保医院和门诊单位之间有效的医疗过渡;(v)加强并致力于对初级保健医生的培训以及患者的心脏康复。对于心力衰竭的预防,提出了以下建议/提议:(i)开展提高心血管疾病危险因素认知的活动;(ii)促进体育锻炼和健康饮食;(iii)避免在危险因素管理中出现治疗惰性。
专家们对各种战略因素的认可及其优先级排序,使得为心力衰竭的管理与预防制定并强化一系列新的战略建议成为可能。